Sign in

NCT05200364CompletedPhase 1

A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor alpha (FolRα) Antibody Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
20 (actual)
First submitted
14 Oct 2024
Start date
23 Nov 2022
Lead sponsor
Sutro Biopharma Inc.
NCT number
NCT05200364
EU CT number
2024-513708-33-00
EudraCT number
2021-006293-23

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 20
  • 9 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainCompleted
University Hospital Virgen Del Rocio S.L.
Coordinator of this site? Confirm its status
SevillaSpainCompleted
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceCompleted
Institut De Cancerologie De L Ouest
Coordinator of this site? Confirm its status
Saint-Herblain CedexFranceCompleted
Istituto Europeo di Oncologia s.r.l
Coordinator of this site? Confirm its status
MilanItalyCompleted
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Coordinator of this site? Confirm its status
NaplesItalyCompleted
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyCompleted

This page is information, not medical advice. Discuss any trial with your doctor.